Triamcinolone Acetonide

曲安奈德

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameTriamcinolone Acetonide
Drug Alias NameTriamcinolono acetonidas曲安奈德缓释制剂Triamcinoloni acetonidumTriamcynolonu acetonidTriamsinolon Asetonid +[28] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsPlaque psoriasisDiabetic macular oedemaOcular inflammation +[112] 
Global Approved IndicationsPlaque psoriasisLichen PlanusAlopecia Areata +[15] 
Approved Indications in ChinaPlaque psoriasisLichen PlanusAlopecia Areata +[14] 
Original Approved Country/TerritoryUnited States
Original Approved Date1960/01/04
Country/TerritoryCanadaUnited StatesPoland +[23] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesDar Al Uloom UniversityPacira Biosciences IncHarrow Health Inc +[31] 
Inactive CompaniesFederal University Of Sao PauloUniversity of Sao PauloExtrovis EU Ltd +[38] 
Active IndicationsPlaque psoriasisDiabetic macular oedemaOcular inflammation +[44] 
Inactive IndicationsLow Back PainFibrosisDrug Hypersensitivity +[68] 

Other Information

ATC CodeA01AC01C05AA12D07AB09 +[8] 
Related LinksWikipediaDrugBankKEGG